000			02008 a2200565 4500
005			20250515174428.0
264		0	_c20110906
008			201109s 0 0 eng d
022			_a1469-5111
024	7		_a10.1017/S1461145709990101 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlvarez, X Anton
245	0	0	_aReduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin. _h[electronic resource]
260			_bThe international journal of neuropsychopharmacology _cAug 2009
300			_a867-72 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlzheimer Disease _xblood
650	0	4	_aAmino Acids _xtherapeutic use
650	0	4	_aBiomarkers _xblood
650	0	4	_aCognition _xdrug effects
650	0	4	_aDisability Evaluation
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDown-Regulation
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInsulin-Like Growth Factor I _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aNootropic Agents _xtherapeutic use
650	0	4	_aPlacebo Effect
650	0	4	_aSeverity of Illness Index
650	0	4	_aSpain
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xblood
650	0	4	_aUp-Regulation
700	1		_aSampedro, Carolina
700	1		_aCacabelos, Ramon
700	1		_aLinares, Carlos
700	1		_aAleixandre, Manuel
700	1		_aGarcía-Fantini, Manuel
700	1		_aMoessler, Herbert
773	0		_tThe international journal of neuropsychopharmacology _gvol. 12 _gno. 7 _gp. 867-72
856	4	0	_uhttps://doi.org/10.1017/S1461145709990101 _zAvailable from publisher's website
999			_c18949971 _d18949971